Results 271 to 280 of about 66,239 (358)

Clinical therapeutics in feline medicine: updates for old and new drugs. [PDF]

J Feline Med Surg
Susi IR, Viviano K, Whitehouse WH.
europepmc   +1 more source

A Cost-Effectiveness Analysis of Rivaroxaban Compared to Warfarin for the Management of Venous Thromboembolism in Western Kenya. [PDF]

Clin Drug Investig
O'Neill ET, Huang AW, Wilson-Barthes M, Manji I, Kigen G, Busakhala N, Nyanje S, Galárraga O, Pastakia SD.   +8 more
europepmc   +1 more source

Rivaroxaban and Hemopericardium – Is There an Association?

Austin Cardio & Cardiovascular Case Reports, 2017
openaire   +1 more source

Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program

, 2014
Brahim Bookhart, Lloyd Haskell, Luke Bamber, Maria Wang, Jeff Schein, Samir H. Mody   +5 more
openalex   +1 more source

Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies. [PDF]

Eur Heart J Cardiovasc Pharmacother
Rubboli A, Angiolillo DJ, Becattini C, Lip GYH.   +3 more
europepmc   +1 more source

Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapy. [PDF]

Res Pract Thromb Haemost
Foulon-Pinto G, Jourdi G, Delrue M, Lafuente-Lafuente C, Cavalie C, Gouin-Thibault I, Le Guen J, Gaussem P, Mirault T, Puymirat E, Lecompte T, Pautas E, Curis E, Siguret V.   +13 more
europepmc   +1 more source

Heparin resistance in a patient with severe acute pancreatitis: a case report. [PDF]

Lab Med
Rongqin D, Zhexin B, Yuzhi L, Zhenbin G, Jinbiao Z.   +4 more
europepmc   +1 more source

Rebound warfarin toxicity presenting with spontaneous hemopericardium in cardiac tamponade: a case report. [PDF]

Int J Emerg Med
Rinzin U, Gurung M.
europepmc   +1 more source

Selective targeting of coagulation factor X Gla domain by negatively charged gold nanoparticles: a novel method for controlled antithrombotic therapy. [PDF]

Mater Today Bio
Li S, Yin Y, Hou D, Jin Y, Zhao Y, Tong J, Liu X, Shen G, Yue T, Liu K, Gu Y, Chen L, Ren F, Huang J, Tie JK, Hao Z.   +15 more
europepmc   +1 more source

Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study). [PDF]

Front Pharmacol
Montero-Balosa MC, Limón-Mora JA, Leal-Atienza A, García-Robredo B, Sánchez-Villegas P, Isabel-Gómez R, Aguado-Romeo MJ, Luque Romero LG, Molina-López MT.   +8 more
europepmc   +1 more source